COMORBIDITIES AND DEATHS BY COVID-19 IN BRAZIL
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | por eng |
Título da fonte: | Revista Uningá (Online) |
Texto Completo: | https://revista.uninga.br/uninga/article/view/4054 |
Resumo: | The new coronavirus outbreak in November 2019 quickly became an international public health emergency. Some studies demonstrate that the poor prognosis of the disease is directly related to the presence of comorbidities, with a risk of death increased by 3.4 times. Thus, the present study aimed to describe the cases of patients with Covid-19 that progressed to death in Brazil, evidencing age, sex, and presence of comorbidities. A retrospective, descriptive study was carried out with secondary data from patients with Covid-19 who progressed to death in Brazil, available on the websites of the health departments of each of the 27 federative units that make up the country. Data were tabulated and frequencies calculated in Microsoft Office Excel® 2007. There were 13,900,091 confirmed cases of Covid-19 until the 59th National Epidemiological Bulletin of 2021, of which 371,678 evolved to death; of them, 61.3% had comorbidities. Among the main comorbidities reported, heart disease (40.1%), diabetes (28.4%), obesity (10.3%), neurological diseases (5.0%), kidney diseases (4.7%) and pneumopathies (4.5%) stand out. In 70% of the cases of patients who died, age equal to or greater than 60 years was observed in males in 55% of the cases. The data obtained corroborate the literature, which indicate a poor prognosis of Covid-19 in patients with one or more comorbidities. Among these, the one that stood out in Brazil during the study period was heart disease. |
id |
UNINGA-1_74c95a9aba2189ce47c5fbbdccca6965 |
---|---|
oai_identifier_str |
oai:ojs.revista.uninga.br:article/4054 |
network_acronym_str |
UNINGA-1 |
network_name_str |
Revista Uningá (Online) |
repository_id_str |
|
spelling |
COMORBIDITIES AND DEATHS BY COVID-19 IN BRAZILCOMORBIDADES E ÓBITOS POR COVID-19 NO BRASILBrasilcomorbidadesCovid-19mortesSARS-CoV-2CoronavírusBrazilcomorbiditiesCovid-19deathsSARS-CoV-2CoronavirusThe new coronavirus outbreak in November 2019 quickly became an international public health emergency. Some studies demonstrate that the poor prognosis of the disease is directly related to the presence of comorbidities, with a risk of death increased by 3.4 times. Thus, the present study aimed to describe the cases of patients with Covid-19 that progressed to death in Brazil, evidencing age, sex, and presence of comorbidities. A retrospective, descriptive study was carried out with secondary data from patients with Covid-19 who progressed to death in Brazil, available on the websites of the health departments of each of the 27 federative units that make up the country. Data were tabulated and frequencies calculated in Microsoft Office Excel® 2007. There were 13,900,091 confirmed cases of Covid-19 until the 59th National Epidemiological Bulletin of 2021, of which 371,678 evolved to death; of them, 61.3% had comorbidities. Among the main comorbidities reported, heart disease (40.1%), diabetes (28.4%), obesity (10.3%), neurological diseases (5.0%), kidney diseases (4.7%) and pneumopathies (4.5%) stand out. In 70% of the cases of patients who died, age equal to or greater than 60 years was observed in males in 55% of the cases. The data obtained corroborate the literature, which indicate a poor prognosis of Covid-19 in patients with one or more comorbidities. Among these, the one that stood out in Brazil during the study period was heart disease.O surto pelo novo coronavírus em novembro de 2019 tornou-se rapidamente uma emergência de saúde pública a nível internacional. Alguns estudos demonstram que o mau prognóstico da doença está diretamente relacionado à presença de comorbidades, com um risco de óbito aumentado em 3,4 vezes. Assim, o presente estudo teve por objetivo descrever os casos de pacientes com COVID-19que evoluíram para óbito no Brasil, evidenciando a idade, sexo e presença de comorbidades. Foi realizado um estudo retrospectivo, comparativo, com dados secundários de pacientes com COVID-19 que evoluíram para óbito no Brasil, disponíveis nos sites das secretárias de saúde de cada uma das 27 unidades federativas que compõem o país. Foram registrados 13.900.091casos confirmados de COVID-19 até o 59º Boletim Epidemiológico Nacional, desses 371.678 evoluíram para o óbito, dos quais 61,3% apresentaram comorbidades. Dentre as principais comorbidades relatadas destaca-se cardiopatias (40,1%), diabetes (28,4%), obesidade (10,3%), doença neurológica (5,0%), doença renal (4,7%) e pneumopatia (4,5%). Em 70% dos casos de pacientes que evoluíram ao óbito apresentavam idade igual ou superior a 60 anos e sexo masculino em55% dos casos. Os dados obtidos corroboram com a literatura indicando mau prognóstico da COVID-19 em pacientes com uma ou mais comorbidades, entre estas, o que se destacou no Brasil no período estudado foram as cardiopatias especialmente no paciente idoso.Editora Uningá2021-12-22info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionTextoinfo:eu-repo/semantics/otherapplication/pdfapplication/pdfhttps://revista.uninga.br/uninga/article/view/405410.46311/2318-0579.58.eUJ4054Revista Uningá; Vol. 58 (2021); eUJ4054Revista Uningá; v. 58 (2021); eUJ40542318-057910.46311/ru.v58i0reponame:Revista Uningá (Online)instname:Centro Universitário Uningáinstacron:UNINGAporenghttps://revista.uninga.br/uninga/article/view/4054/2459https://revista.uninga.br/uninga/article/view/4054/246010.46311/ru.v58i0.4054.g245910.46311/ru.v58i0.4054.g2460Copyright (c) 2021 UNINGÁ JOURNALhttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessSouza, Izabella Ventura deScodro, Regiane Bertin de LimaDias Siqueira, Vera LúciaFressatti Cardoso, RosileneCaleffi-Ferracioli, Katiany Rizzieri2023-10-20T18:43:58Zoai:ojs.revista.uninga.br:article/4054Revistahttps://revista.uninga.br/uninga/indexPUBhttps://revista.uninga.br/uninga/oairevistauninga@uninga.edu.br2318-05792318-0579opendoar:2023-10-20T18:43:58Revista Uningá (Online) - Centro Universitário Uningáfalse |
dc.title.none.fl_str_mv |
COMORBIDITIES AND DEATHS BY COVID-19 IN BRAZIL COMORBIDADES E ÓBITOS POR COVID-19 NO BRASIL |
title |
COMORBIDITIES AND DEATHS BY COVID-19 IN BRAZIL |
spellingShingle |
COMORBIDITIES AND DEATHS BY COVID-19 IN BRAZIL Souza, Izabella Ventura de Brasil comorbidades Covid-19 mortes SARS-CoV-2 Coronavírus Brazil comorbidities Covid-19 deaths SARS-CoV-2 Coronavirus |
title_short |
COMORBIDITIES AND DEATHS BY COVID-19 IN BRAZIL |
title_full |
COMORBIDITIES AND DEATHS BY COVID-19 IN BRAZIL |
title_fullStr |
COMORBIDITIES AND DEATHS BY COVID-19 IN BRAZIL |
title_full_unstemmed |
COMORBIDITIES AND DEATHS BY COVID-19 IN BRAZIL |
title_sort |
COMORBIDITIES AND DEATHS BY COVID-19 IN BRAZIL |
author |
Souza, Izabella Ventura de |
author_facet |
Souza, Izabella Ventura de Scodro, Regiane Bertin de Lima Dias Siqueira, Vera Lúcia Fressatti Cardoso, Rosilene Caleffi-Ferracioli, Katiany Rizzieri |
author_role |
author |
author2 |
Scodro, Regiane Bertin de Lima Dias Siqueira, Vera Lúcia Fressatti Cardoso, Rosilene Caleffi-Ferracioli, Katiany Rizzieri |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Souza, Izabella Ventura de Scodro, Regiane Bertin de Lima Dias Siqueira, Vera Lúcia Fressatti Cardoso, Rosilene Caleffi-Ferracioli, Katiany Rizzieri |
dc.subject.por.fl_str_mv |
Brasil comorbidades Covid-19 mortes SARS-CoV-2 Coronavírus Brazil comorbidities Covid-19 deaths SARS-CoV-2 Coronavirus |
topic |
Brasil comorbidades Covid-19 mortes SARS-CoV-2 Coronavírus Brazil comorbidities Covid-19 deaths SARS-CoV-2 Coronavirus |
description |
The new coronavirus outbreak in November 2019 quickly became an international public health emergency. Some studies demonstrate that the poor prognosis of the disease is directly related to the presence of comorbidities, with a risk of death increased by 3.4 times. Thus, the present study aimed to describe the cases of patients with Covid-19 that progressed to death in Brazil, evidencing age, sex, and presence of comorbidities. A retrospective, descriptive study was carried out with secondary data from patients with Covid-19 who progressed to death in Brazil, available on the websites of the health departments of each of the 27 federative units that make up the country. Data were tabulated and frequencies calculated in Microsoft Office Excel® 2007. There were 13,900,091 confirmed cases of Covid-19 until the 59th National Epidemiological Bulletin of 2021, of which 371,678 evolved to death; of them, 61.3% had comorbidities. Among the main comorbidities reported, heart disease (40.1%), diabetes (28.4%), obesity (10.3%), neurological diseases (5.0%), kidney diseases (4.7%) and pneumopathies (4.5%) stand out. In 70% of the cases of patients who died, age equal to or greater than 60 years was observed in males in 55% of the cases. The data obtained corroborate the literature, which indicate a poor prognosis of Covid-19 in patients with one or more comorbidities. Among these, the one that stood out in Brazil during the study period was heart disease. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-12-22 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Texto info:eu-repo/semantics/other |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://revista.uninga.br/uninga/article/view/4054 10.46311/2318-0579.58.eUJ4054 |
url |
https://revista.uninga.br/uninga/article/view/4054 |
identifier_str_mv |
10.46311/2318-0579.58.eUJ4054 |
dc.language.iso.fl_str_mv |
por eng |
language |
por eng |
dc.relation.none.fl_str_mv |
https://revista.uninga.br/uninga/article/view/4054/2459 https://revista.uninga.br/uninga/article/view/4054/2460 10.46311/ru.v58i0.4054.g2459 10.46311/ru.v58i0.4054.g2460 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2021 UNINGÁ JOURNAL https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2021 UNINGÁ JOURNAL https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Editora Uningá |
publisher.none.fl_str_mv |
Editora Uningá |
dc.source.none.fl_str_mv |
Revista Uningá; Vol. 58 (2021); eUJ4054 Revista Uningá; v. 58 (2021); eUJ4054 2318-0579 10.46311/ru.v58i0 reponame:Revista Uningá (Online) instname:Centro Universitário Uningá instacron:UNINGA |
instname_str |
Centro Universitário Uningá |
instacron_str |
UNINGA |
institution |
UNINGA |
reponame_str |
Revista Uningá (Online) |
collection |
Revista Uningá (Online) |
repository.name.fl_str_mv |
Revista Uningá (Online) - Centro Universitário Uningá |
repository.mail.fl_str_mv |
revistauninga@uninga.edu.br |
_version_ |
1797042158830616576 |